Funder
Comisión Nacional de Energía Atómica, Gobierno de Argentina
Fondo para la Investigación Científica y Tecnológica
Consejo Nacional de Investigaciones Científicas y Técnicas
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference47 articles.
1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2014) Cronin K SEER Cancer Statistics Review, 1975–2011, National Cancer Institute, Bethesda, Md, USA, 2013, based on November 2013 SEER data submission, posted to the SEER web site http://seer.cancer.gov/csr/1975_2011/. Accessed 25 July 2022
2. Veness MJ, Porter GS, Morgan GJ (2004) Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach. ANZ J Surg 74(7):559–562. https://doi.org/10.1111/j.1445-2197.2004.03062.x
3. Smallridge RC, Ain KB, Asaetal SL (2012) American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 22(11):1104–1139. https://doi.org/10.1089/thy.2012.0302
4. Busnardo B, Daniele O, Pelizzo MR, Mazzarotto R, Nacamulli D, Devido D, Mian C, Girelli ME (2000) A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. J Endocrinol Invest 23(11):755–761. https://doi.org/10.1007/BF03345066
5. Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91(12):2335–2342